Disseminated intravascular coagulation and a negative D-dimer test

Netherlands Journal of Medicine

Volumn 65, Issue 10, 2007, Pages 398-400

  Constantinescu, A A ^a   Berendes, P B ^a   Levin, M D ^a  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

D dimer; Disseminated intravascular coagulation

Indexed keywords

D DIMER; FIBRIN; FIBRINOGEN DEGRADATION PRODUCT; TRANEXAMIC ACID;

AGED; ANAMNESIS; ARTICLE; CANCER RELAPSE; CASE REPORT; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DISSEMINATED INTRAVASCULAR CLOTTING; FALSE NEGATIVE RESULT; HEMATOMA; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; PARANEOPLASTIC SYNDROME; PHYSICAL EXAMINATION; PROTEIN DETERMINATION;

AGED; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE;

EID: 36448953935     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
2. Woodside KJ, Hunter GC. Disseminated intravascular coagulation scoring systems in the critical ill. Crit Care Med 2006;34:899-900.
3. Bakhtiari K, Meijers JCM, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2006;32:2416-21.
4. Dempfle CE. D-dimer assays: The current status and new assay technologies. Thromb Res 2006;118:569-71.
5. Freyburger G, Labrouche S. Comparability of D-dimer assays in clinical samples. Semin Vasc Med 2005;5:328-39.
6. Gaffney PJ. Fibrin degradation products. A review of structures found in vitro and in vivo. Ann N Y Acad Sci 2001;936:594-610.
7. Gaffney PJ. Distinction between fibrinogen and fibrin degradation products in plasma. Clin Chem Acta 1975;65:109-15.
8. Bucek RA, Quehenberger P, Feliks I, Handler S, Reiter M, Minar E. Results of a new rapid D-dimer assay (Cardiac D-dimer) in the diagnosis of deep vein thrombosis. Thromb Res 2001;103:17-23.
9. Dempfle CE, Korte W, Schwab E, Zerback R, Huisman MV. Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis. Thromb Haemost 2006;95:79-83.
10. Dempfle CE, Wurst M. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of ISTH overt DIC score. Thromb Haemost 2004;91:812-8.
11. Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Haemost 2001;27:657-66.
12. Yeh KH, Cheng AL. Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin. Br J Haematol 1998;100:769-72.